STOCK TITAN

10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
10x Genomics, Inc. (TXG) will release its financial results for Q1 2024 on April 30, 2024. A conference call and webcast will follow to discuss results, business updates, and future prospects.
Positive
  • None.
Negative
  • None.

PLEASANTON, Calif., April 10, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the first quarter ended March 31, 2024 after market close on Tuesday, April 30, 2024. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

Live audio of the webcast will be available on the "Investors" section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts 
Investors: investors@10xgenomics.com 
Media: media@10xgenomics.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-first-quarter-2024-financial-results-on-april-30-2024-302113577.html

SOURCE 10x Genomics, Inc

FAQ

When will 10x Genomics (TXG) release its financial results for Q1 2024?

10x Genomics (TXG) will release its financial results for the first quarter of 2024 on April 30, 2024.

What time will the conference call and webcast to discuss financial results take place?

The conference call and live webcast to discuss 10x Genomics' financial results will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Where can investors access the news release with the financial results?

Investors can access the news release with 10x Genomics' financial results on the company's website prior to the conference call.

Will the webcast discussing financial results be available for replay?

Yes, the webcast discussing 10x Genomics' financial results will be archived and available for replay for at least 45 days after the event.

10x Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Stock Data

3.15B
102.65M
2.38%
92.4%
7.15%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States of America
PLEASANTON

About TXG

advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.